Journal of Cancer Research and Therapeutics Close
 

Figure 2: Planning target volume coverage (95% of dose) in transfer, sagittal, and coronal view of Hybrid (a), volumetric-modulated arc therapy (b)

Figure 2: Planning target volume coverage (95% of dose) in transfer, sagittal, and coronal view of Hybrid (a), volumetric-modulated arc therapy (b)